Market Research Logo

Global Diabetes Care Market (Insulin, OAD & GLP-1): Industry Analysis & Outlook (2019-2023)

Global Diabetes Care Market (Insulin, OAD & GLP-1): Industry Analysis & Outlook (2019-2023)

Diabetes, referred to diabetes mellitus, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Diabetes can either be due to pancreas not producing enough insulin or irresponsiveness of cells of the body to insulin. Insulin is a hormone which regulates the metabolism of carbohydrates, fat and protein by absorbing glucose (sugar) from the blood into fat, liver and skeletal muscles.

Diabetic population is growing considerably all over the world. AAMEO region is experiencing the highest prevalence of diabetes compared to other parts of world. Increasing population in AAMEO countries is the key reason supporting the diabetic population. Every geographical region is witnessing growth in their respective diabetes care market due to this increasing prevalence of diabetes.

Global diabetes care market is majorly dominated by insulin segment. Insulin segment is broadly divided into modern insulin and human insulin. Modern insulin is growing at a faster rate than human insulin market. In terms of mode of action, insulin market is dominated by long acting insulin.

Geographically, North America holds the highest share in global diabetes care market due to its advanced healthcare system along with increasing diabetic population. However, in global insulin market, Europe holds the highest share.

Global diabetes market is highly consolidated in nature with three key players including Novo Nordisk; Sanofi; and Eli Lilly. These three companies are holding major shares in every regional diabetes market. Among all these companies, Novo Nordisk is leading in every region.


1. Overview
1.1 Diabetes
Table 1: Type of Diabetes
1.2 Symptoms of Diabetes
Table 2: Symptoms of Diabetes
1.3 Diagnosis of Diabetes
1.4 Diabetes Management
2. Global Diabetes Market
2.1 Diabetes Population Forecast
Table 3: Global Diabetes Population Forecast (2018-2023)
2.2 Diabetes Care Market Value Forecast
Table 4: Global Diabetes Care Market Value Forecast (2014-2023)
2.3 Diabetes Care Market by Type
Table 5: Global Diabetes Care Market by Type (2018)
2.3.1 Global Insulin Market Value Forecast
Table 6: Global Insulin Market Value Forecast (2014-2023)
2.3.2 Global OAD Market Value Forecast
Table 7: Global OAD Market Value Forecast (2014-2023)
2.3.3 Global GLP-1 Market Value Forecast
Table 8: Global GLP-1 Market Value Forecast (2014-2023)
2.4 Diabetes Care Market by Region
Table 9: Global Diabetes Care Market by Region (2018)
3. Regional Diabetes Market
3.1 North America
3.1.1 North America Diabetes Care Market Value Forecast
Table 10: North America Diabetes Care Market Value Forecast (2014-2023)
3.1.2 North America Insulin Market Value Forecast
Table 11: North America Insulin Market Value Forecast (2014-2023)
3.1.3 North America OAD Market Value Forecast
Table 12: North America OAD Market Value Forecast (2014-2023)
3.1.4 North America GLP-1 Market Value Forecast
Table 13: North America GLP-1 Market Value Forecast (2014-2023)
3.2 Europe
3.2.1 Europe Diabetes Care Market Value Forecast
Table 14: Europe Diabetes Care Market Value Forecast (2014-2023)
3.2.2 Europe Insulin Market Value Forecast
Table 15: Europe Insulin Market Value Forecast (2014-2023)
3.2.3 Europe OAD Market Value Forecast
Table 16: Europe OAD Market Value Forecast (2014-2023)
3.2.4 Europe GLP-1 Market Value Forecast
Table 17: Europe GLP-1 Market Value Forecast (2014-2023)
3.3 Japan & Korea
3.3.1 Japan & Korea Diabetes Care Market Value Forecast
Table 18: Japan & Korea Diabetes Care Market Value Forecast (2014-2023)
3.3.2 Japan & Korea Insulin Market Value Forecast
Table 19: Japan & Korea Insulin Market Value Forecast (2014-2023)
3.3.3 Japan & Korea OAD Market Value Forecast
Table 20: Japan & Korea OAD Market Value Forecast (2014-2023)
3.3.4 Japan & Korea GLP-1 Market Value Forecast
Table 21: Japan & Korea GLP-1 Market Value Forecast (2014-2023)
3.4 AAMEO
3.4.1 AAMEO Diabetes Care Market Value Forecast
Table 22: AAMEO Diabetes Care Market Value Forecast (2014-2023)
3.4.2 AAMEO Insulin Market Value Forecast
Table 23: AAMEO Insulin Market Value Forecast (2014-2023)
3.4.3 AAMEO OAD Market Value Forecast
Table 24: AAMEO OAD Market Value Forecast (2014-2023)
3.4.4 AAMEO GLP-1 Market Value Forecast
Table 25: AAMEO GLP-1 Market Value Forecast (2014-2023)
3.5 China
3.5.1 China Diabetes Care Market Value Forecast
Table 26: China Diabetes Care Market Value Forecast (2014-2023)
3.5.2 China Insulin Market Value Forecast
Table 27: China Insulin Market Value Forecast (2014-2023)
3.5.3 China OAD Market Value Forecast
Table 28: China OAD Market Value Forecast (2014-2023)
3.5.4 China GLP-1 Market Value Forecast
Table 29: China GLP-1 Market Value Forecast (2014-2023)
3.6 Latin America
3.6.1 Latin America Diabetes Care Market Value Forecast
Table 30: Latin America Diabetes Care Market Value Forecast (2014-2023)
3.6.2 Latin America Insulin Market Value Forecast
Table 31: Latin America Insulin Market Value Forecast (2014-2023)
3.6.3 Latin America OAD Market Value Forecast
Table 32: Latin America OAD Market Value Forecast (2014-2023)
3.6.4 Latin America GLP-1 Market Value Forecast
Table 33: Latin America GLP-1 Market Value Forecast (2014-2023)
4. Insulin Market Analysis
4.1 Global Insulin Market Volume Forecast
Table 34: Global Insulin Market Volume Forecast (2014-2023)
4.2 Global Insulin Market Volume by Type
Table 35: Global Insulin Market Volume by Type (2018)
4.2.1 Global Long Acting Insulin Market Volume Forecast
Table 36: Global Long Acting Insulin Market Volume Forecast (2014-2023)
4.2.2 Global Fast Acting Insulin Market Volume Forecast
Table 37: Global Fast Acting Insulin Market Volume Forecast (2014-2023)
4.2.3 Global Premix Insulin Market Volume Forecast
Table 38: Global Premix Insulin Market Volume Forecast (2014-2023)
4.3 Global Insulin Market Volume by Region
Table 39: Global Insulin Market Volume by Region (2018)
4.3.1 Europe Insulin Market Volume Forecast
Table 40: Europe Insulin Market Volume Forecast (2014-2023)
4.3.2 Europe Long Acting Insulin Market Volume Forecast
Table 41: Europe Long Acting Insulin Market Volume Forecast (2014-2023)
4.3.3 Europe Fast Acting Insulin Market Volume Forecast
Table 42: Europe Fast Acting Insulin Market Volume Forecast (2014-2023)
4.3.4 Europe Premix Insulin Market Volume Forecast
Table 43: Europe Premix Insulin Market Volume Forecast (2014-2023)
4.3.5 North America Insulin Market Volume Forecast
Table 44: North America Insulin Market Volume Forecast (2014-2023)
4.3.6 North America Long Acting Insulin Market Volume Forecast
Table 45: North America Long Acting Insulin Market Volume Forecast (2014-2023)
4.3.7 North America Fast Acting Insulin Market Volume Forecast
Table 46: North America Fast Acting Insulin Market Volume Forecast (2014-2023)
4.3.8 North America Premix Insulin Market Volume Forecast
Table 47: North America Premix Insulin Market Volume Forecast (2014-2023)
4.3.9 AAMEO Insulin Market Volume Forecast
Table 48: AAMEO Insulin Market Volume Forecast (2014-2023)
4.3.10 AAMEO Long Acting Insulin Market Volume Forecast
Table 49: AAMEO Long Acting Insulin Market Volume Forecast (2014-2023)
4.3.11 AAMEO Fast Acting Insulin Market Volume Forecast
Table 50: AAMEO Fast Acting Insulin Market Volume Forecast (2014-2023)
4.3.12 AAMEO Premix Insulin Market Volume Forecast
Table 51: AAMEO Premix Insulin Market Volume Forecast (2014-2023)
4.3.13 China Insulin Market Volume Forecast
Table 52: China Insulin Market Volume Forecast (2014-2023)
4.3.14 Latin America Insulin Market Volume Forecast
Table 53: Latin America Insulin Market Volume Forecast (2014-2023)
4.3.15 Latin America Long Acting Insulin Market Volume Forecast
Table 54: Latin America Long Acting Insulin Market Volume Forecast (2014-2023)
4.3.16 Latin America Fast Acting Insulin Market Volume Forecast
Table 55: Latin America Fast Acting Insulin Market Volume Forecast (2014-2023)
4.3.17 Latin America Premix Insulin Market Volume Forecast
Table 56: Latin America Premix Insulin Market Volume Forecast (2014-2023)
4.3.18 Japan & Korea Insulin Market Volume Forecast
Table 57: Japan & Korea Insulin Market Volume Forecast (2014-2023)
4.3.19 Japan & Korea Long Acting Insulin Market Volume Forecast
Table 58: Japan & Korea Long Acting Insulin Market Volume Forecast (2014-2023)
4.3.20 Japan & Korea Fast Acting Insulin Market Volume Forecast
Table 59: Japan & Korea Fast Acting Insulin Market Volume Forecast (2014-2023)
4.3.21 Japan & Korea Premix Insulin Market Volume Forecast
Table 60: Japan & Korea Premix Insulin Market Volume Forecast (2014-2023)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Acceleration of Ageing Population
Table 61: Global Ageing Population above 65 Years (2014-2018)
5.1.2 Increasing Obesity Rates
Table 62: Global Obese Population (2014-2018)
5.1.3 Longer Life Expectancy at Birth
Table 63: Global Life Expectancy at Birth (2014-2018)
5.1.4 Accelerating Economic Growth
Table 64: Global GDP Per Capita (2014-2018)
5.1.5 Rising Healthcare Expenditure
Table 65: Global Healthcare Expenditure Per Capita (2014-2018)
5.2 Key Trends & Developments
5.2.1 Increasing Awareness
5.2.2 Rise of Digital Diabetes Care
5.3 Challenges
5.3.1 Stringent Legal Norms
5.3.2 High Cost and Alternative Treatments
6. Competitive Landscape
6.1 Global Diabetes Market Share by Company
Table 66: Global Diabetes Market Share by Company (2018)
6.2 Global Modern & New Generation Insulin Market Share by Company
Table 67: Global Modern Insulin (MI) & New Generation Insulin (NGI) Market Share by Company (2018)
6.3 North America Market
6.3.1 North America MI and NGI Market Share by Company
Table 68: North America MI and NGI Market Share by Company (2018)
6.4 Europe Market
6.4.1 Europe MI & NGI Market Share by Company
Table 69: Europe MI & NGI Market Share by Company (2018)
6.4.2 Europe GLP-1 Market Share by Company
Table 70: Europe GLP-1 Market Share by Company (2018)
6.5 AAMEO Market
6.5.1 AAMEO MI & NGI Market Share by Company
Table 71: AAMEO MI & NGI Market Share by Company (2018)
6.5.2 AAMEO GLP-1 Market Share by Company
Table 72: AAMEO GLP-1 Market Share by Company (2018)
6.6 Japan & Korea Market
6.6.1 Japan Total Insulin Market Share by Company
Table 73: Japan Total Insulin Market Share by Company (2018)
6.6.2 J&K MI & NGI Market Share by Company
Table 74: J&K MI & NGI Market Share by Company (2018)
6.6.3 J&K GLP-1 Market Share by Company
Table 75: J&K GLP-1 Market Share by Company (2018)
6.7 China Market
6.7.1 China Total Insulin Market Share by Company
Table 76: China Total Insulin Market Share by Company (2018)
6.7.2 China GLP-1 Market Share by Company
Table 77: China GLP-1 Market Share by Company (2018)
6.8 Latin America Market
6.8.1 Latin America MI & NGI Market Share by Company
Table 78: Latin America MI & NGI Market Share by Company (2018)
6.8.2 Latin America GLP-1 Market Share by Company
Table 79: Latin America GLP-1 Market Share by Company (2018)
7. Company Profiles
7.1 Merck Group
7.1.1 Business Overview
Table 80: Merck Group Sales by Segment (2018)
7.1.2 Financial Overview
Table 81: Merck Group Net Sales and Net Income (2014-2018)
7.1.3 Business Strategies
7.2 Novo Nordisk
7.2.1 Business Overview
Table 82: Novo Nordisk Sales by Segment (2018)
7.2.2 Financial Overview
Table 83: Novo Nordisk Net Sales and Net Income (2014-2018)
7.2.3 Business Strategies
7.3 Eli Lilly and Company
7.3.1 Business Overview
Table 84: Eli Lilly and Company Revenue by Segments (2018)
7.3.2 Financial Overview
Table 85: Eli Lilly and Company Revenue and Net Income (2014-2018)
7.3.3 Business Strategies
Table 86: Eli Lilly and Company Research and Development Expenditure (2016-2018)
7.4 Sanofi S.A.
7.4.1 Business Overview
Table 87: Sanofi S.A. Net Sales by Segment (2018)
7.4.2 Financial Overview
Table 88: Sanofi S.A. Net Sales and Net Income (2014-2018)
7.4.3 Business Strategies
Table 89: Sanofi S.A. R&D Expenditure (2016-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook